MX9702275A - Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento. - Google Patents
Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento.Info
- Publication number
- MX9702275A MX9702275A MX9702275A MX9702275A MX9702275A MX 9702275 A MX9702275 A MX 9702275A MX 9702275 A MX9702275 A MX 9702275A MX 9702275 A MX9702275 A MX 9702275A MX 9702275 A MX9702275 A MX 9702275A
- Authority
- MX
- Mexico
- Prior art keywords
- phe
- lys
- alkyltryptophan
- promoting
- release
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 title abstract 2
- -1 imidazoleacetyl Chemical group 0.000 abstract 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 1
- 150000008575 L-amino acids Chemical class 0.000 abstract 1
- SDNVRAKIJVKAGS-LKTVYLICSA-N Tyr-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N SDNVRAKIJVKAGS-LKTVYLICSA-N 0.000 abstract 1
- ZQOOYCZQENFIMC-STQMWFEESA-N Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=C(O)C=C1 ZQOOYCZQENFIMC-STQMWFEESA-N 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se refiere a un péptido de la formula: A-D-Mrp(Ala)n-B-C, en donde A es cualquier L-aminoácido natural o su D-isomero, siempre y cuando A no sea His si B es Trp y C es D-Phe-Lys-NH2; o A es imidazolacetilo, isonipecotilo, 4-aminobutirilo, 4-(aminometil) ciclohexilcarbonilo, Glu-Try-Ala-His, Try-Ala-His, Try-His, D-Trys-His; D se refiere al isomero dextrogiro, Mrp es 2-alquiltriptofano; n es 0 o 1; B es L- o D-Trp, Php o D-Beta-naftilalanina, C es NH2, D-Phe-LysNH2, D-Trp-LysNH2, D-Phe-LysNH2, Phe-LysNH2, D-Phe-Lys-ThrNH2, D-Phe-Lys-D-ThrNH2, OR, en donde R es un grupo alquilo de 1 a 3 átomos de carbono; y las sales de adiccion con ácidos orgánicos o inorgánicos farmacéuticamente aceptables de cualquiera de dichos polipéptidos, en donde estos compuestos son capaces de promover la liberacion de hormona del crecimiento y son activos por la vía oral.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI941954A IT1270021B (it) | 1994-09-27 | 1994-09-27 | "composti polipeptidici contenenti d-2-metiltriptofano aventi attivita'sull'aumento del camp intracellulare" |
| MIMI94A001954 | 1994-09-27 | ||
| IT95MI001293A IT1276734B1 (it) | 1995-06-16 | 1995-06-16 | Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della |
| MIMI95A001293 | 1995-06-16 | ||
| PCT/EP1995/003601 WO1996010040A1 (en) | 1994-09-27 | 1995-09-13 | Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97002275A MXPA97002275A (es) | 1997-06-01 |
| MX9702275A true MX9702275A (es) | 1997-06-28 |
Family
ID=26331189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9702275A MX9702275A (es) | 1994-09-27 | 1995-09-13 | Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5795957A (es) |
| EP (1) | EP0783521B8 (es) |
| JP (1) | JP3810083B2 (es) |
| KR (1) | KR100369105B1 (es) |
| CN (1) | CN1121413C (es) |
| AT (1) | ATE225806T1 (es) |
| AU (1) | AU700066B2 (es) |
| CA (1) | CA2201122A1 (es) |
| CZ (1) | CZ291798B6 (es) |
| DE (1) | DE69528531T2 (es) |
| DK (1) | DK0783521T3 (es) |
| ES (1) | ES2186730T3 (es) |
| HK (1) | HK1001207A1 (es) |
| HU (1) | HU221481B (es) |
| IL (1) | IL115381A (es) |
| MX (1) | MX9702275A (es) |
| PL (1) | PL181588B1 (es) |
| PT (1) | PT783521E (es) |
| RU (1) | RU2157378C2 (es) |
| SK (1) | SK284550B6 (es) |
| WO (1) | WO1996010040A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| US20020111461A1 (en) | 1999-05-21 | 2002-08-15 | Todd C. Somers | Low molecular weight peptidomimetic growth hormone secretagogues |
| IT1277113B1 (it) * | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
| WO1999039730A1 (fr) * | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Preparation a administration orale contenant des peptides favorisant la secretion d'hormone de croissance |
| US5932548A (en) * | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
| US6696063B1 (en) | 1998-12-30 | 2004-02-24 | Applied Research Systems Ars Holding N.V. | Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy |
| US6211156B1 (en) * | 1999-11-10 | 2001-04-03 | Asta Medica A.G. | Peptides for treatment of erectile dysfunction |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
| GB0603295D0 (en) | 2006-02-18 | 2006-03-29 | Ardana Bioscience Ltd | Methods and kits |
| US8728528B2 (en) | 2007-12-20 | 2014-05-20 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1080470A (en) * | 1963-12-31 | 1967-08-23 | Merck & Co Inc | Indole derivatives |
| US4411890A (en) * | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228156A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223021A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4224316A (en) * | 1979-03-30 | 1980-09-23 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4226857A (en) * | 1979-03-30 | 1980-10-07 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228157A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223020A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228158A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228155A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223019A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4410513A (en) * | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| AU549053B2 (en) * | 1981-12-28 | 1986-01-09 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4410512A (en) * | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Combinations having synergistic pituitary growth hormone releasing activity |
| US4725577A (en) * | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
| US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| DE68922602T2 (de) * | 1988-01-28 | 1995-12-07 | Polygen Holding Corp | Polypeptide mit hormonwachstumsbefreiender wirkung. |
| DE3915361A1 (de) * | 1989-05-11 | 1990-11-15 | Merck Patent Gmbh | Cyclopeptide |
| IT1240643B (it) * | 1990-05-11 | 1993-12-17 | Mediolanum Farmaceutici Spa | Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano |
| JPH08502250A (ja) * | 1992-09-25 | 1996-03-12 | スミスクライン・ビーチャム・コーポレイション | 成長ホルモン放出ペプチド |
-
1995
- 1995-09-13 CZ CZ1997914A patent/CZ291798B6/cs not_active IP Right Cessation
- 1995-09-13 CN CN95195323A patent/CN1121413C/zh not_active Expired - Fee Related
- 1995-09-13 JP JP51131596A patent/JP3810083B2/ja not_active Expired - Fee Related
- 1995-09-13 PT PT95932735T patent/PT783521E/pt unknown
- 1995-09-13 EP EP95932735A patent/EP0783521B8/en not_active Expired - Lifetime
- 1995-09-13 CA CA002201122A patent/CA2201122A1/en not_active Abandoned
- 1995-09-13 ES ES95932735T patent/ES2186730T3/es not_active Expired - Lifetime
- 1995-09-13 DK DK95932735T patent/DK0783521T3/da active
- 1995-09-13 DE DE69528531T patent/DE69528531T2/de not_active Expired - Fee Related
- 1995-09-13 MX MX9702275A patent/MX9702275A/es not_active IP Right Cessation
- 1995-09-13 WO PCT/EP1995/003601 patent/WO1996010040A1/en active IP Right Grant
- 1995-09-13 AT AT95932735T patent/ATE225806T1/de not_active IP Right Cessation
- 1995-09-13 RU RU97107089/04A patent/RU2157378C2/ru not_active IP Right Cessation
- 1995-09-13 AU AU35668/95A patent/AU700066B2/en not_active Ceased
- 1995-09-13 KR KR1019970701987A patent/KR100369105B1/ko not_active IP Right Cessation
- 1995-09-13 HU HU9800136A patent/HU221481B/hu not_active IP Right Cessation
- 1995-09-13 SK SK399-97A patent/SK284550B6/sk unknown
- 1995-09-13 PL PL95319382A patent/PL181588B1/pl unknown
- 1995-09-20 US US08/530,853 patent/US5795957A/en not_active Expired - Fee Related
- 1995-09-21 IL IL11538195A patent/IL115381A/xx not_active IP Right Cessation
-
1998
- 1998-01-02 HK HK98100002A patent/HK1001207A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2201122A1 (en) | 1996-04-04 |
| JPH10506114A (ja) | 1998-06-16 |
| DE69528531D1 (de) | 2002-11-14 |
| PT783521E (pt) | 2003-02-28 |
| WO1996010040A1 (en) | 1996-04-04 |
| CZ91497A3 (en) | 1997-09-17 |
| HK1001207A1 (en) | 1998-06-05 |
| JP3810083B2 (ja) | 2006-08-16 |
| US5795957A (en) | 1998-08-18 |
| AU3566895A (en) | 1996-04-19 |
| EP0783521A1 (en) | 1997-07-16 |
| PL181588B1 (pl) | 2001-08-31 |
| ATE225806T1 (de) | 2002-10-15 |
| ES2186730T3 (es) | 2003-05-16 |
| RU2157378C2 (ru) | 2000-10-10 |
| PL319382A1 (en) | 1997-08-04 |
| DK0783521T3 (da) | 2003-01-27 |
| SK39997A3 (en) | 1997-09-10 |
| HU221481B (en) | 2002-10-28 |
| AU700066B2 (en) | 1998-12-17 |
| CN1158622A (zh) | 1997-09-03 |
| CN1121413C (zh) | 2003-09-17 |
| KR100369105B1 (ko) | 2003-04-07 |
| IL115381A (en) | 2000-07-16 |
| EP0783521B1 (en) | 2002-10-09 |
| DE69528531T2 (de) | 2003-06-05 |
| HUT77525A (hu) | 1998-05-28 |
| SK284550B6 (sk) | 2005-06-02 |
| IL115381A0 (en) | 1995-12-31 |
| KR970706305A (ko) | 1997-11-03 |
| CZ291798B6 (cs) | 2003-05-14 |
| EP0783521B8 (en) | 2003-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9702275A (es) | Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento. | |
| DE3686200D1 (de) | Biologisch wirksame lysin enthaltende octapeptide. | |
| SE9101838D0 (sv) | Novel peptides and their use | |
| IT1277113B1 (it) | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita | |
| ES2012720A6 (es) | Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada. | |
| BG105638A (en) | Antagonist analogs of gh-rh inhibiting igf-i and -ii | |
| RU97107089A (ru) | Полипептидные соединения, содержащие d-2-алкилтриптофан, стимулирующий высвобождение гормона роста | |
| MY103251A (en) | Biologically active molecules | |
| NO894720L (no) | Farmasoeytisk aktivt protein. | |
| US5807985A (en) | Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone | |
| NZ511618A (en) | Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X | |
| IT1276734B1 (it) | Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della | |
| DE3665462D1 (en) | Pharmacologically active peptides | |
| IT1270021B (it) | "composti polipeptidici contenenti d-2-metiltriptofano aventi attivita'sull'aumento del camp intracellulare" | |
| RU96119245A (ru) | Новые пептиды типа опиоидов для обезболивания и их применение | |
| TH1762EX (th) | เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี | |
| TH26711A (th) | " สิ่งที่คล้ายกันของปัจจัยหลั่งฮอโมนของการเจริญเติบโต " |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |